Koyfin Home > Directory > Health Care > Illumina Inc

Illumina Inc Price Chart ILMN

Historical daily share price chart and data for Illumina Inc since 2000 adjusted for splits and dividends. The latest closing price for Illumina Inc as of August 22, 2019 is $288.58.
  • In 2019 the stock opened at $294.71 and closed at $288.58 for a loss of -2% YTD.
  • In 2018 the stock opened at $224.78 and closed at $299.93 for a gain of 25%.
  • In 2017 the stock opened at $129.17 and closed at $218.49 for a gain of 41%.
  • In 2016 the stock opened at $187.65 and closed at $128.04 for a loss of -47%.
View Chart On Koyfin

Illumina Inc Summary

Stock Symbol: ILMN

Illumina Inc Company Info

Illumina, Inc. provides sequencing and array-based solutions for genetic analysis. The company operates in two segments, Core Illumina and Consolidated VIEs. It offers sequencing that provides researchers with various applications and the ability to sequence mammalian genomes; and arrays for a range of deoxyribonucleic acid and RNA analysis applications, including single nucleotide polymorphism genotyping, copy number variations analysis, gene expression analysis, and methylation analysis, as well as enables the detection of known genetic markers on a single array. The company also provides various library preparation and sequencing kits to simplify workflows and accelerate analysis; and genome sequencing, genotyping, and noninvasive prenatal testing, as well as products support services. It serves genomic research centers, academic institutions, government laboratories, and hospitals; and pharmaceutical, biotechnology, and commercial molecular diagnostic laboratories, as well as consumer genomics companies. The company markets and distributes its products directly to customers, as well as through life-science distributors. Illumina, Inc. has a partnership with Lundbeck Foundation GeoGenetics Centre for exploring the relationship between the evolutionary history of select mental and neurological disorders and infectious pathogens; and an agreement with HTG Molecular Diagnostics, Inc. for the development of nuclease-protection-based RNA or DNA profiling tests. It operates in North America, Europe, Latin America, the Asia-Pacific region, the Middle East, and South Africa. Illumina, Inc. was founded in 1998 and is headquartered in San Diego, California.
Market Cap
Dividend Yield
0 %
Beta vs SPX
Short Interest
374.65 %
30D Volatility
Hedge Fund Held
2.02 %

Last 10 Days of ILMN Prices